3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Breast
1
Conditions
Pain, Postoperative
9
Pain
5
Neuralgia
5
Breast Neoplasms
5
Agnosia
4
Neoplasms
3
Head and Neck Neoplasms
2
Chronic Pain
2
Visceral Pain
1
Squamous Cell Carcinoma of Head and Neck
1
Spinal Cord Neoplasms
1
Seizures
1
Pinealoma
1
Persistent Postoperative Pain
1
Pancreatic Neoplasms
1
Pain, Intractable
1
Oropharyngeal Neoplasms
1
Oligodendroglioma
1
Obesity
1
Neuroectodermal Tumors, Primitive
1
Myotoxicity
1
Mouth Neoplasms
1
Meningioma
1
Medulloblastoma
1
Lymphoma, Follicular
1
Lymphoma
1
Liver Neoplasms
1
Leiomyoma
1
Inflammation
1
Hot Flashes
1
Interventions
Exercise
24
Metformin
23
Resistance Training
8
Nutrition Assessment
8
Methods
8
Tirzepatide
7
Diet Therapy
7
Diet
7
Counseling
7
Early Intervention, Educational
6
Caloric Restriction
6
Exenatide
5
semaglutide
4
Liraglutide
4
Educational Status
4
Docosahexaenoic Acids
4
Diet, Mediterranean
4
Vitamin D
3
Therapeutics
3
Surveys and Questionnaires
3
Sugars
3
Standard of Care
3
Dexamethasone
3
Yoga
2
Tablets
2
Specimen Handling
2
Progestins
2
Ovidrel
2
Nutritional Status
2
Naltrexone
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Obesity
×
Pregabalin
×
Clear all
NCT06150898
2025-06-13
KePreSt
Jules Bordet Institute
Phase 2
Recruiting
112 enrolled